Comparison of Effectiveness of Implantable Cardioverter Defibrillator in Patients With Idiopathic Dilated Cardiomyopathy Versus Those With Proved Coronary Heart Disease

This study analyzes the effectiveness of the implantable cardioverter defibrillator in a group of 40 consecutive patients with idiopathic dilated cardiomyopathy and sustained ventricular arrhythmia; these patients were compared with a control group of 80 consecutive patients with proved coronary artery disease. There were no differences in the type and probability of recurrences at follow-up. Most recurrences were due to sustained monomorphic ventricular tachycardia, and the efficacy of the defibrillator in treating the arrhythmia was the same in both groups. 2003 by Excerpta Medica, Inc. (Am J Cardiol 2003;92:1227‐1230)

[1]  R. Passman,et al.  Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy. , 2002, The American journal of cardiology.

[2]  D. Cannom,et al.  Comparison of dilated cardiomyopathy and coronary artery disease in patients with life-threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry. , 2001, American heart journal.

[3]  M. Block,et al.  Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. , 2000, Journal of the American College of Cardiology.

[4]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[5]  J. Brugada,et al.  Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation. , 1999, Journal of the American College of Cardiology.

[6]  S. Hohnloser,et al.  Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. , 1998, Journal of the American College of Cardiology.

[7]  A. Schaumann,et al.  Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. , 1998, Circulation.

[8]  F. Marchlinski,et al.  Shock occurrence and survival in 49 patients with idiopathic dilated cardiomyopathy and an implantable cardioverter-defibrillator. , 1995, European heart journal.

[9]  G. Hindricks,et al.  Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. , 1994, European heart journal.

[10]  G. Tomaselli,et al.  Long‐Term Follow‐Up of Patients with Nonischemic Dilated Cardiomyopathy and Ventricular Tachyarrhythmias Treated with Implantable Cardioverter Defibrillators , 1991, Pacing and clinical electrophysiology : PACE.

[11]  C. Swerdlow,et al.  Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. , 1988, The American journal of cardiology.

[12]  P. Brugada,et al.  Ventricular arrhythmias initiated by programmed stimulation in four groups of patients with healed myocardial infarction. , 1986, Journal of the American College of Cardiology.

[13]  M. Josephson,et al.  Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias. , 1984, Circulation.